ARCHIVES

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

November 27, 2009

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

November 7, 1980

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

Broder: Downward Negotiations Or Coercion? NCI Authorities

June 15, 1990

Funding opportunities listed.

October 8, 2004